Amorphous form of N- {2-Fluoro-5-[3-(thiophene-2-carbonyl)-p yrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-a cetamide

Details for Australian Patent Application No. 2007316607 (hide)

Owner Ferrer Internacional, S.A.

Inventors Anglada, Luis; Palomer, Albert; Guglietta, Antonio

Agent Shelston IP

Pub. Number AU-A-2007316607

PCT Pub. Number WO2008/055934

Priority 60/864,814 08.11.06 US; 06123652.7 08.11.06 EP

Filing date 7 November 2007

Wipo publication date 15 May 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/055934 Priority application(s): WO2008/055934

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316613-Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions

2007316606-1,2,3-triazole derivatives as sigma receptor inhibitors